Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Peptic Ulcer

Free Subscription Articles published in Aliment Pharmacol Ther Retrieve available abstracts of 94 articles: HTML format Text format

Single Articles

January 2012
1. SONNENBERG A , Genta RM
   Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease.
   Aliment Pharmacol Ther. 2012 Jan 5. doi: 10.1111/j.1365-2036.2011.04969.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. HASSALL E , Shepherd R, Koletzko S, Radke M, et al
   Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study.
   Aliment Pharmacol Ther. 2011 Dec 18. doi: 10.1111/j.1365-2036.2011.04950.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. GISBERT JP , Calvet X
   Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
   Aliment Pharmacol Ther. 2011 Nov 30. doi: 10.1111/j.1365-2036.2011.04937.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. MALFERTHEINER P , Nocon M, Vieth M, Stolte M, et al
   Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care - the ProGERD study.
   Aliment Pharmacol Ther. 2011 Nov 9. doi: 10.1111/j.1365-2036.2011.04901.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. PARK HG , Jung MK, Jung JT, Kwon JG, et al
   Randomised clinical trial: comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naive patients.
   Aliment Pharmacol Ther. 2011 Nov 8. doi: 10.1111/j.1365-2036.2011.04902.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. SCHMIDT M , Johansen MB, Robertson DJ, Maeng M, et al
   Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
   Aliment Pharmacol Ther. 2011 Nov 4. doi: 10.1111/j.1365-2036.2011.04890.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
7. GISBERT JP , Calvet X
   Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
   Aliment Pharmacol Ther. 2011 Oct 21. doi: 10.1111/j.1365-2036.2011.04887.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. BAVISHI C , Dupont HL
   Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection.
   Aliment Pharmacol Ther. 2011 Oct 17. doi: 10.1111/j.1365-2036.2011.04874.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. HERSHCOVICI T , Jha LK, Johnson T, Gerson L, et al
   Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux disease.
   Aliment Pharmacol Ther. 2011 Oct 17. doi: 10.1111/j.1365-2036.2011.04870.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. GOH KL , Mahadeva S, Ho SH
    Erosive oesophagitis with particular reference to Asians.
    Aliment Pharmacol Ther. 2011;34:821-2.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
11. KIM YS , Kim SJ, Yoon JH, Suk KT, et al
    Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
    Aliment Pharmacol Ther. 2011 Sep 19. doi: 10.1111/j.1365-2036.2011.04843.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. GARCIA-IGLESIAS P , Villoria A, Suarez D, Brullet E, et al
    Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer.
    Aliment Pharmacol Ther. 2011 Sep 7. doi: 10.1111/j.1365-2036.2011.04830.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
13. VELDHUYZEN VAN ZANTEN S , Wahlqvist P, Talley NJ, Halling K, et al
    Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole - results from the STARS II study.
    Aliment Pharmacol Ther. 2011 Aug 17. doi: 10.1111/j.1365-2036.2011.04789.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. HSU CS , Wang PC, Chen JH, Su WC, et al
    Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2011 Aug 17. doi: 10.1111/j.1365-2036.2011.04817.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
15. BECHER A , El-Serag H
    Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2011 Jul 20. doi: 10.1111/j.1365-2036.2011.04774.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. RAVI K , Francis DL, See JA, Geno DM, et al
    The effects of a weakly acidic meal on gastric buffering and postprandial gastro-oesophageal reflux.
    Aliment Pharmacol Ther. 2011 Jul 5. doi: 10.1111/j.1365-2036.2011.04761.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. LUO JC , Huang KW, Leu HB, Chen LC, et al
    Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer.
    Aliment Pharmacol Ther. 2011 Jul 5. doi: 10.1111/j.1365-2036.2011.04760.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. CHACKO Y , Holtmann GJ
    Helicobacter pylori eradication and weight gain: has it opened a Pandora's box?
    Aliment Pharmacol Ther. 2011;34:256.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
19. GERSON LB , Bonafede M, Princic N, Gregory C, et al
    Development of a refractory gastro-oesophageal reflux score using an administrative claims database.
    Aliment Pharmacol Ther. 2011 Jun 30. doi: 10.1111/j.1365-2036.2011.04755.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. CHAVEZ-TAPIA NC , Barrientos-Gutierrez T, Tellez-Avila F, Soares-Weiser K, et al
    Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review.
    Aliment Pharmacol Ther. 2011 Jun 27. doi: 10.1111/j.1365-2036.2011.04746.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. SHARMA P , Johnson DA, Monyak JT, Illueca M, et al
    Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors.
    Aliment Pharmacol Ther. 2011 Jun 20. doi: 10.1111/j.1365-2036.2011.04736.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. SAVARINO E , Gemignani L, Pohl D, Zentilin P, et al
    Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2011 Jun 14. doi: 10.1111/j.1365-2036.2011.04742.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
23. MCQUAID KR , Laine L, Fennerty MB, Souza R, et al
    Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia.
    Aliment Pharmacol Ther. 2011 May 25. doi: 10.1111/j.1365-2036.2011.04709.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. BAI Y , Guo JF, Li ZS
    Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding.
    Aliment Pharmacol Ther. 2011 May 25. doi: 10.1111/j.1365-2036.2011.04708.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. SAINI SD , Fendrick AM, Scheiman JM
    Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary prevention.
    Aliment Pharmacol Ther. 2011 May 25. doi: 10.1111/j.1365-2036.2011.04707.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. MORELLI G , Chen H, Rossiter G, Rege B, et al
    Rabeprazole extended-release 50 mg compared with esomeprazole 40 mg and rabeprazole delayed release 20 mg: authors' reply.
    Aliment Pharmacol Ther. 2011;33:1179-1180.
    PubMed     Text format     Related articles   
    
    
    
    
27. YUAN Y , Hunt RH
    Rabeprazole extended-release 50 mg compared with esomeprazole 40 mg and rabeprazole delayed release 20 mg.
    Aliment Pharmacol Ther. 2011;33:1177-1179.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
28. LANAS A , Aabakken L, Fonseca J, Mungan ZA, et al
    Clinical predictors of poor outcomes among patients with nonvariceal upper gastrointestinal bleeding in Europe.
    Aliment Pharmacol Ther. 2011 Apr 11. doi: 10.1111/j.1365-2036.2011.04651.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
29. DE BORTOLI N , Martinucci I, Piaggi P, Maltinti S, et al
    Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett's oesophagus for 1 year.
    Aliment Pharmacol Ther. 2011 Mar 8. doi: 10.1111/j.1365-2036.2011.04616.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. LANE JA , Murray LJ, Harvey IM, Donovan JL, et al
    Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study.
    Aliment Pharmacol Ther. 2011 Mar 2. doi: 10.1111/j.1365-2036.2011.04610.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
31. ZERBIB F , Bruley des Varannes S, Roman S, Tutuian R, et al
    Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2011 Feb 14. doi: 10.1111/j.1365-2036.2011.04596.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. HASSALL E , Owen D, Kerr W, Sturby T, et al
    Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell-like hyperplasia.
    Aliment Pharmacol Ther. 2011 Feb 14. doi: 10.1111/j.1365-2036.2011.04592.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. DISNEY BR , Watson RD, Blann AD, Lip GY, et al
    Review article: proton pump inhibitors with clopidogrel - evidence for and against a clinically-important interaction.
    Aliment Pharmacol Ther. 2011 Feb 8. doi: 10.1111/j.1365-2036.2011.04585.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
34. MORELLI G , Chen H, Rossiter G, Rege B, et al
    An open-label, parallel, multiple-dose study comparing the pharmacokinetics and gastric acid suppression of rabeprazole extended-release with esomeprazole 40 mg and rabeprazole delayed-release 20 mg in healthy volunteers.
    Aliment Pharmacol Ther. 2011 Jan 28. doi: 10.1111/j.1365-2036.2011.04580.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. HERSHCOVICI T , Jha LK, Cui H, Powers J, et al
    Night-time intra-oesophageal bile and acid: a comparison between gastro-oesophageal reflux disease patients who failed and those who were treated successfully with a proton pump inhibitor.
    Aliment Pharmacol Ther. 2011 Jan 25. doi: 10.1111/j.1365-2036.2011.04583.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. KESSING BF , Conchillo JM, Bredenoord AJ, Smout AJ, et al
    Review article: the clinical relevance of transient lower oesophageal sphincter relaxations in gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2011 Jan 10. doi: 10.1111/j.1365-2036.2010.04565.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. AHSBERG K , Ye W, Lu Y, Zheng Z, et al
    Hospitalisation of and mortality from bleeding peptic ulcer in Sweden: a nationwide time-trend analysis.
    Aliment Pharmacol Ther. 2011 Jan 6. doi: 10.1111/j.1365-2036.2010.04562.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. KUNSCH S , Gross V, Neesse A, Sohrabi K, et al
    Combined lung-sound and reflux-monitoring: a pilot study of a novel approach to detect nocturnal respiratory symptoms in gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2011 Jan 4. doi: 10.1111/j.1365-2036.2010.04559.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. BUTTON LA , Roberts SE, Evans PA, Goldacre MJ, et al
    Hospitalized incidence and case fatality for upper gastrointestinal bleeding from 1999 to 2007: a record linkage study.
    Aliment Pharmacol Ther. 2011;33:64-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
40. FRAZZONI M , Conigliaro R, Melotti G
    Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis.
    Aliment Pharmacol Ther. 2010 Dec 29. doi: 10.1111/j.1365-2036.2010.04550.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. MIEHLKE S , Lobe S, Madisch A, Kuhlisch E, et al
    Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping.
    Aliment Pharmacol Ther. 2010 Dec 22. doi: 10.1111/j.1365-2036.2010.04544.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. CORVAGLIA L , Aceti A, Mariani E, De Giorgi M, et al
    The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.
    Aliment Pharmacol Ther. 2010 Dec 15. doi: 10.1111/j.1365-2036.2010.04545.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. BECHER A , Dent J
    Systematic review: ageing and gastro-oesophageal reflux disease symptoms, oesophageal function and reflux oesophagitis.
    Aliment Pharmacol Ther. 2010 Dec 8. doi: 10.1111/j.1365-2036.2010.04542.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. DALL M , Schaffalitzky de Muckadell OB, Lassen AT, Hallas J, et al
    There is an association between selective serotonin reuptake inhibitor use and uncomplicated peptic ulcers: a population-based case-control study.
    Aliment Pharmacol Ther. 2010;32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. MIWA H , Inoue K, Ashida K, Kogawa T, et al
    Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study.
    Aliment Pharmacol Ther. 2010 Dec 1. doi: 10.1111/j.1365-2036.2010.04517.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
46. DABHOLKAR AH , Han C, Paris MM, Perez MC, et al
    The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2010 Nov 30. doi: 10.1111/j.1365-2036.2010.04519.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. LAINE L , Katz PO, Johnson DA, Ibegbu I, et al
    Randomised clinical trial: a novel rabeprazole extended release 50 mg formulation vs. esomeprazole 40 mg in healing of moderate-to-severe erosive oesophagitis - the results of two double-blind studies.
    Aliment Pharmacol Ther. 2010 Nov 30. doi: 10.1111/j.1365-2036.2010.04516.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. GADDAM S , Wani S, Ahmed H, Maddur P, et al
    The impact of pre-endoscopy proton pump inhibitor use on the classification of non-erosive reflux disease and erosive oesophagitis.
    Aliment Pharmacol Ther. 2010;32:1266-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. WILDER-SMITH C , Rohss K, Bokelund Singh S, Sagar M, et al
    The effects of dose and timing of esomeprazole administration on 24-h, daytime and night-time acid inhibition in healthy volunteers.
    Aliment Pharmacol Ther. 2010;32:1249-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. RUBENSTEIN JH , Taylor JB
    Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux.
    Aliment Pharmacol Ther. 2010;32:1222-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. KESZTHELYI D , Jansen SV, Schouten GA, De Kort S, et al
    Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study.
    Aliment Pharmacol Ther. 2010;32:1124-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. SZAJEWSKA H , Horvath A, Piwowarczyk A
    Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment.
    Aliment Pharmacol Ther. 2010;32:1069-79.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. GOLDSTEIN JL , Jungwirthova A, David J, Spindel E, et al
    Clinical trial: endoscopic evaluation of naproxen etemesil, a naproxen prodrug, vs. naproxen - a proof-of-concept, randomized, double-blind, active-comparator study.
    Aliment Pharmacol Ther. 2010;32:1091-101.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
54. MEINECHE-SCHMIDT V , Christensen E, Bytzer P
    Randomised clinical trial: identification of responders to short-term treatment with esomeprazole for dyspepsia in primary care - a randomised, placebo-controlled study.
    Aliment Pharmacol Ther. 2010 Oct 29. doi: 10.1111/j.1365-2036.2010.04501.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. VALKHOFF VE , 't Jong GW, Van Soest EM, Kuipers EJ, et al
    Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors.
    Aliment Pharmacol Ther. 2010 Oct 19. doi: 10.1111/j.1365-2036.2010.04485.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. ABU-SNEINEH A , Tam W, Schoeman M, Fraser R, et al
    The effects of high-dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett's oesophagus.
    Aliment Pharmacol Ther. 2010;32:1023-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
57. VAEZI MF , Slaughter JC, Smith BS, Washington MK, et al
    Dilated intercellular space in chronic laryngitis and gastro-oesophageal reflux disease: at baseline and post-lansoprazole therapy.
    Aliment Pharmacol Ther. 2010 Aug 2. doi: 10.1111/j.1365-2036.2010.04420.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. MOLINA-INFANTE J , Gisbert JP
    One size does not fit all - time to regionalize Helicobacter pylori eradication? authors' reply.
    Aliment Pharmacol Ther. 2010;32:507-8.
    PubMed     Text format     Related articles   
    
    
    
    
59. TAN VP , Wong BC
    One size does not fit all - time to regionalize Helicobacter pylori eradication?
    Aliment Pharmacol Ther. 2010;32:506-7.
    PubMed     Text format     Related articles   
    
    
    
    July 2010
60. FLETCHER EH , Johnston DE, Fisher CR, Koerner RJ, et al
    Systematic review: Helicobacter pylori and upper gastrointestinal bleeding risk in patients taking aspirin.
    Aliment Pharmacol Ther. 2010 Jul 26. doi: 10.1111/j.1365-2036.2010.04415.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. SONNENBERG A , Baron JH
    Rising trends of gastric cancer and peptic ulcer in the 19th century.
    Aliment Pharmacol Ther. 2010 Jul 26. doi: 10.1111/j.1365-2036.2010.04413.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. EL-SERAG H , Becher A, Jones R
    Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies.
    Aliment Pharmacol Ther. 2010 Jul 20. doi: 10.1111/j.1365-2036.2010.04406.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. YUEN E , Romney M, Toner RW, Cobb NM, et al
    Prevalence, knowledge and care patterns for gastro-oesophageal reflux disease in United States minority populations.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. AHSBERG K , Hoglund P, Stael von Holstein C
    Mortality from peptic ulcer bleeding: the impact of comorbidity and the use of drugs that promote bleeding.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. FASS R
    Patients vote with their feet for 'On demand' rabeprazole in the maintenance treatment phase of reflux oesophagitis: author's reply.
    Aliment Pharmacol Ther. 2010;32:307-8.
    PubMed     Text format     Related articles   
    
    
    
    
66. TAN VP , Wong BC
    Patients vote with their feet for 'On demand' rabeprazole in the maintenance treatment phase of reflux oesophagitis.
    Aliment Pharmacol Ther. 2010;32:305-7.
    PubMed     Text format     Related articles   
    
    
    
    June 2010
67. SPIEGEL BM , Roberts L, Mody R, Harding G, et al
    Development and validation of a nocturnal gastro-oesophageal reflux disease symptom severity and impact questionnaire (N-GSSIQ) for adults.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
68. CALABRESE C , Spisni E, Liguori G, Lazzarini G, et al
    Potential role of the cannabinoid receptor CB1 in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. GOLDSTEIN JL , Hochberg MC, Fort JG, Zhang Y, et al
    Clinical trial: incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. BOECKXSTAENS GE , Smout A
    Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastroesophageal reflux disease.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. MINER JR P , Plachetka J, Orlemans E, Fort JG, et al
    Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen / esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg -
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. HARVEY RF , Lane JA, Nair P, Egger M, et al
    Clinical trial: the prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations - the Bristol Helicobacter Project.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. HEARNSHAW SA , Logan RF, Palmer KR, Card TR, et al
    Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
74. JOHNSON D , Crawley JA, Hwang C, Brown K, et al
    Clinical trial: esomeprazole for moderate to severe nighttime heartburn and gastroesophageal reflux disease-related sleep disturbances.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. TALWAR V , Wurm P, Bankart MJ, Gershlick AH, et al
    Clinical trial: chest pain due to presumed gastro-oesophageal reflux in coronary artery disease - controlled study of lansoprazole versus placebo.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. MORGAN D , Pandolfino J, Katz PO, Goldstein JL, et al
    Clinical trial: gastric acid suppression in Hispanic adults with symptomatic gastroesophageal reflux disease - comparator study of esomeprazole, lansoprazole, and pantoprazole.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. THUKKANI N , Sonnenberg A
    The influence of environmental risk factors in hospitalization for gastro-oesophageal reflux disease-related diagnoses in the United States.
    Aliment Pharmacol Ther. 2010;31:852-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
78. CREMONINI F , Ziogas D, Chang HY, Kokkotou E, et al
    Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. HABER MM , Hunt B, Freston JW, Peura DA, et al
    Gastric histology changes in patients with erosive esophagitis receiving long-term lansoprazole maintenance therapy.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. CAMERON C , VAN Zanten SV, Skedgel C, Flowerdew G, et al
    Cost-utility analysis of proton pump inhibitors and other gastro-protective agents for prevention of gastrointestinal complications in elderly patients taking non-selective non-steroidal anti-inflammatory agents.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. JOHNSTONE J , Nerenberg K, Loeb M
    Meta-analysis: proton pump inhibitor use and risk of community acquired pneumonia.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
82. MARTIN-MERINO E , Ruigomez A, Garcia Rodriguez LA, Wallander MA, et al
    Depression and treatment with antidepressants are associated with the development of gastroesophageal reflux disease.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. LEE RD , Mulford D, Wu J, Atkinson SN, et al
    The effect of time-of-day dosing on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR - evidence for dosing flexibility with a Dual Delayed Release proton pump inhibitor.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. MOLINA-INFANTE J , Perez-Gallardo B, Fernandez-Bermejo M, Hernandez-Alonso M, et al
    Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. MINER JR PB , McKean LA, Gibb RD, Erasala GN, et al
    Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. FASS R , Delemos B, Nazareno L, Kao R, et al
    Clinical trial: maintenance intermittent therapy with rabeprazole 20 mg in patients with symptomatic gastro-oesophageal reflux disease - a double-blind, placebo-controlled, randomized study.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. MINER P , Delemos B, Xiang J, Lococo J, et al
    Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24-hour intragastric acidity and oesophageal acid exposure: a randomised, study in gastroesophageal reflux disease (GERD) patients with a history of nocturnal heartburn.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. HIRAISHI H , Haruma K, Miwa H, Goto H, et al
    Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection - the results of a multicentre, double-blind, randomised clinical trial (IMPACT study).
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
89. KWOK CS , Loke YK
    Meta-analysis: effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. JOHNSON T , Gerson L, Hershcovici T, Stave C, et al
    Systematic review: the effect of carbonated beverages on gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. HART J , Hawkey CJ, Lanas A, Naesdal J, et al
    Predictors of gastroduodenal erosions in patients taking low-dose aspirin.
    Aliment Pharmacol Ther. 2010;31:143-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2009
92. DESAI JC , Goo T, Fukata M, Sanyal S, et al
    NSAID-induced antral ulcers are associated with distinct changes in mucosal gene expression.
    Aliment Pharmacol Ther. 2009;30:71-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2009
93. LABENZ J , Armstrong D, Zetterstrand S, Eklund S, et al
    Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis--results from the maintenance phase of the EXPO study.
    Aliment Pharmacol Ther. 2009;29:1165-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2009
94. VAN VLIET EP , Steyerberg EW, Otten HJ, Rudolphus A, et al
    The effects of guideline implementation for proton pump inhibitor prescription on two pulmonary medicine wards.
    Aliment Pharmacol Ther. 2009;29:213-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: